These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32658845)

  • 1. [Neutrophil to lymphocyte ratio as a prognostic marker in COVID-19].
    Basbus L; Lapidus MI; Martingano I; Puga MC; Pollán J
    Medicina (B Aires); 2020; 80 Suppl 3():31-36. PubMed ID: 32658845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
    Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
    Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.
    Yang AP; Liu JP; Tao WQ; Li HM
    Int Immunopharmacol; 2020 Jul; 84():106504. PubMed ID: 32304994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.
    Liu J; Liu Y; Xiang P; Pu L; Xiong H; Li C; Zhang M; Tan J; Xu Y; Song R; Song M; Wang L; Zhang W; Han B; Yang L; Wang X; Zhou G; Zhang T; Li B; Wang Y; Chen Z; Wang X
    J Transl Med; 2020 May; 18(1):206. PubMed ID: 32434518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of neutrophil-lymphocyte ratio and lymphocyte-monocyte ratio in the prognosis of type 2 diabetics with COVID-19.
    Liu G; Zhang S; Hu H; Liu T; Huang J
    Scott Med J; 2020 Nov; 65(4):154-160. PubMed ID: 32865157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
    Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
    Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis.
    Li X; Liu C; Mao Z; Xiao M; Wang L; Qi S; Zhou F
    Crit Care; 2020 Nov; 24(1):647. PubMed ID: 33198786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with coronavirus disease 2019 (COVID-19): a retrospective cohort study in a single medical centre.
    Wang X; Li X; Shang Y; Wang J; Zhang X; Su D; Zhao S; Wang Q; Liu L; Li Y; Chen H
    Epidemiol Infect; 2020 Sep; 148():e211. PubMed ID: 32900409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China.
    Li C; Chen Q; Wang J; Lin H; Lin Y; Lin J; Peng F; Chen J; Yang Z
    Aging (Albany NY); 2020 Aug; 12(16):15938-15945. PubMed ID: 32855361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.
    Liu Y; Du X; Chen J; Jin Y; Peng L; Wang HHX; Luo M; Chen L; Zhao Y
    J Infect; 2020 Jul; 81(1):e6-e12. PubMed ID: 32283162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive value of neutrophil/lymphocyte ratio on myocardial injury in severe COVID-19 patients].
    Chen Y; Wang KJ; Luo YC; Wang BZ; Zhang MM; Xu YQ; Yang YN; Ma YT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):572-579. PubMed ID: 32842269
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.
    Peng J; Qi D; Yuan G; Deng X; Mei Y; Feng L; Wang D
    J Clin Lab Anal; 2020 Oct; 34(10):e23475. PubMed ID: 32681559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.
    Haghjooy Javanmard S; Vaseghi G; Manteghinejad A; Nasirian M
    J Glob Antimicrob Resist; 2020 Sep; 22():862-863. PubMed ID: 32810639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients.
    Pimentel GD; Dela Vega MCM; Laviano A
    Clin Nutr ESPEN; 2020 Dec; 40():101-102. PubMed ID: 33183520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale Use of Neutrophil-to-lymphocyte ratio for early diagnosis and stratification of COVID-19.
    Zahorec R; Hulin I; Zahorec P
    Bratisl Lek Listy; 2020; 121(7):466-470. PubMed ID: 32989997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
    Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
    Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China.
    Peng Y; Meng K; He M; Zhu R; Guan H; Ke Z; Leng L; Wang X; Liu B; Hu C; Ji Q; Keerman M; Cheng L; Wu T; Huang K; Zeng Q
    J Am Heart Assoc; 2020 Oct; 9(19):e016796. PubMed ID: 32794415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-to-lymphocyte ratio predicts the clearance of SARS-CoV-2 RNA in mild COVID-19 patients - a retrospective analysis from Dongxihu Fangcang Hospital in Wuhan, China.
    Zhu C; Yu S; Zhao H; Shen H; Yang J; Zhao L; Wu W
    Clin Chem Lab Med; 2020 Aug; 58(9):e167-e170. PubMed ID: 32609644
    [No Abstract]   [Full Text] [Related]  

  • 19. Interleukin-6 and severity of COVID-19 patients in Hefei, China.
    Zhao Z; Xie J; Yin M; Yang Y; Ding C; Gao Y; Ma X
    Med Mal Infect; 2020 Oct; 50(7):629-631. PubMed ID: 32593746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
    Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
    Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.